The process of drug development is incredibly complex, and I’ve been thinking about the hurdles that come up during clinical trials. For instance, obtaining FDA approval can take over a decade, and even then, the rate of successful candidates is still shockingly low. I’m curious to hear how others perceive these challenges and any innovative solutions they might have come across.
One thing I’ve seen is the value of adaptive trial designs; they can really help in addressing uncertainties during trials. It might not solve everything, but it can improve efficiency. Has anyone here tried using that approach?
I totally get your frustration with the timelines; it drives me nuts! I once worked on a project that got stalled for years just waiting for FDA feedback. It helped us realize that early engagement with the agency could streamline things, though it still didn’t guarantee success.